Soliton

Soliton is developing game-changing science to address multiple multibillion-dollar market opportunities. They spent over 25 million dollars over the past 5 years developing a breakthrough technology that dramatically accelerates the removal of tattoos. Their devices use very high energy, in the range of 3,000 volts at nearly 3,000 amps, to form acoustic shockwaves at 100 times per second.  Soliton's core team is comprised of life science veterans, with more than 150 years of life science experience, multiple device clearances, and multiple national and international aesthetic device launches.

HOUSTON, Jan. 26, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced it has entered into a collaboration with the US Navy to conduct a multi-treatment proof-of-concept...

Soliton Announces Collaboration with US Navy to Conduct Proof-of-Concept Study for Fibrotic Scars

HOUSTON, Dec. 30, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced the appointment of Sean J. Shapiro as Vice President of Sales, effective January 1, 2021. Brad...

Soliton Appoints Sean J. Shapiro as Vice President of Sales

Soliton, Inc. (SOLY) CEO Brad Hauser on Q3 2020 Results - Earnings Call Transcript

HOUSTON, Nov. 12, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial results for the third quarter ended September 30, 2020. Third Quarter Company Highlights:...

Soliton Reports Third Quarter 2020 Results

HOUSTON, Nov. 2, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the appointment of Brad A. Hauser as President and Chief Executive Officer of Soliton. He...

Soliton Appoints Aesthetic Executive Veteran Brad Hauser as President and Chief Executive Officer in Preparation for Commercial Launch

HOUSTON, Oct. 27, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced it has appointed Michael S. Kaminer, M.D. to Soliton's Board of Directors. "Dr. Kaminer...

Soliton Appoints Dr. Michael Kaminer to Board of Directors

HOUSTON, Oct. 5, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the Company has been accepted to present its pivotal cellulite data via an online poster...

Soliton to Present Poster on Pivotal Cellulite Data at Virtual American Society for Dermatologic Surgery (ASDS) 2020 Annual Meeting

HOUSTON, Sept. 8, 2020 /PRNewswire/ -- Soliton, Inc.

Soliton to Present at the Cantor Virtual Global Healthcare Conference

HOUSTON, Aug. 26, 2020 /PRNewswire/ -- Soliton, Inc.

Soliton Initiates New Tooling Production Process for Improved Cartridge in RAP Device

HOUSTON, Aug. 20, 2020 /PRNewswire/ -- Soliton, Inc.

Soliton Announces Presentations at Masters in Aesthetics Symposium

HOUSTON, Aug. 13, 2020 /PRNewswire/ -- Soliton, Inc.

Soliton Introduces Advanced Design for RAP Cartridges

Soliton, Inc.'s (SOLY) CEO Chris Capelli on Q2 2020 Results - Earnings Call Transcript

HOUSTON, Aug. 11, 2020 /PRNewswire/ -- Soliton, Inc.

Soliton Reports Second Quarter 2020 Results

HOUSTON, Aug. 5, 2020 /PRNewswire/ -- Soliton, Inc.

Soliton Appoints Dr. Sachin Shridharani to Scientific Advisory Board

HOUSTON, July 29, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, announced today that it will report its second quarter 2020 financial results and provide a business update on.

Soliton Announces Second Quarter 2020 Financial Results and Business Update on Tuesday, August 11, 2020

HOUSTON, July 22, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced Dr.

Soliton Announces Presentation of Pivotal Cellulite Data at Virtual Music City Symposium for Cosmetic Advances & Laser Education (SCALE)

Soliton (SOLY) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Soliton (SOLY) Looks Good: Stock Adds 6.5% in Session

Stock is down nearly 50% in the last few weeks, as a massive share offering well below where the stock was trading sparked selling.

Soliton: Setting Up For A Big Bounce

HOUSTON, June 26, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced the pricing of its underwritten public offering of 4,216,868 shares of common stock at a public...

Soliton Announces Pricing of Public Offering

HOUSTON, June 25, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that it intends to offer shares of its common stock in an underwritten public offering. In...

Soliton Announces Proposed Public Offering of Common Stock

Soliton (SOLY) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Soliton (SOLY) Catches Eye: Stock Jumps 5.2%

Soliton's (SOLY) CEO Chris Capelli on Q1 2020 Results - Earnings Call Transcript

HOUSTON, May 14, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial results for the first quarter ended March 31, 2020. Recent Company Highlights: Announced...

Soliton Reports First Quarter 2020 Results

Soliton: A Solid Play On The Tattoo Removal Opportunity In 2020

Aurora Cannabis

Chesapeake Energy

Gannett Co.

Rite Aid

These 5 stocks all have a real chance of winding up at zero — but if they can avoid that outcome, they could easily triple or more.

News for Soliton Stock (SOLY)